CSL
Vaccins, antivenins et médicaments dérivés du plasma pour l'Australie.
CSL fabrique des vaccins, des antivenins et des médicaments dérivés du plasma pour l'Australie à partir de ses opérations de Melbourne. La société fournit des systèmes de santé, des laboratoires, des partenaires OEM ou des clients exportateurs réglementés sur ses principaux marchés cotés.
- Type
- brand seeking distribution
- Location
- Melbourne, Australia
- Founded
- 1916
- Website
- csldirect.com.au
- Categories
- Fournitures médicales et de santé
- Markets
- Australie, États-Unis, Allemagne, Royaume-Uni
Verified facts
- lei-active (green), checked 2026-08-30 GLEIF global LEI register (golden copy)
- registry-id-verified (green), checked 2026-08-16 Australian Business Register (ABR), Australian Taxation Office
- registry-inactive-global (red), checked 2026-08-16 Australian Business Register (ABR), Australian Taxation Office
- registered-since (green), checked 2026-08-16 Australian Business Register (ABR), Australian Taxation Office
Claimed certifications
- Good Manufacturing Practice
- FDA Registered FDA Establishment Registration
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)